Eiken Chemical Co (TSE:4549) ROCE %: 1.01% (As of Mar. 2026)


TSE:4549 Eiken Chemical Co Ltd TSE:4549
81 GF Score
Price 円2,525.00
GF Value 円2,477.93
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Eiken Chemical Co ROCE %?

Eiken Chemical Co TSE:4549 +1.45% 81 ROCE % is 1.01% as of Mar. 2026. GuruFocus rates TSE:4549 with a GF Score™ of 81/100 and a GF Value™ of 円2,477.93 (Fairly Valued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Eiken Chemical Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 1.01%.


Eiken Chemical Co  (TSE:4549) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Eiken Chemical Co ROCE % Related Terms


Eiken Chemical Co ROCE % Historical Data

* Premium members only.

The historical data trend for Eiken Chemical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eiken Chemical Co ROCE % Chart

Eiken Chemical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.28 14.66 6.76 6.12 10.13

Eiken Chemical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.97 6.95 24.73 8.62 1.01
TSE:4549
81GF Score
Eiken Chemical Co Ltd TSE:4549
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eiken Chemical Co ROCE % Calculation

Eiken Chemical Co's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=4863/( ( (62372 - 14376) + (62657 - 14636) )/ 2 )
=4863/( (47996+48021)/ 2 )
=4863/48008.5
=10.13 %

Eiken Chemical Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=472/( ( (60209 - 15111) + (62657 - 14636) )/ 2 )
=472/( ( 45098 + 48021 )/ 2 )
=472/46559.5
=1.01 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 1.01% mean?
Eiken Chemical Co (TSE:4549) has a ROCE % of 1.01% as of Mar. 2026.
Is Eiken Chemical Co's ROCE % too high?
Eiken Chemical Co's current ROCE % is 1.01%. The Medical Devices & Instruments industry median ROCE % is 2.23. Eiken Chemical Co's value of 1.01% is 54.7% below this industry median. Overall, Eiken Chemical Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eiken Chemical Co's ROCE % compare to ABT and SYK?
Eiken Chemical Co's ROCE % of 1.01% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Eiken Chemical Co's value of 1.01% is 54.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eiken Chemical Co's current ROCE % of 1.01% is 54.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eiken Chemical Co's current ROCE % is 1.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eiken Chemical Co stock overvalued right now?
Based on GuruFocus' analysis, Eiken Chemical Co (TSE:4549) is currently considered Fairly Valued. The stock's GF Value™ is 円2,477.93, compared to a current price of 円2,525.00 — trading 1.9% above its estimated fair value. The current ROCE % is 1.01% and 54.7% below the Medical Devices & Instruments industry median of 2.23. Eiken Chemical Co's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Eiken Chemical Co (TSE:4549), the current ROCE % is 1.01% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eiken Chemical Co (TSE:4549) Overvalued in 2026?

Based on GuruFocus' analysis, Eiken Chemical Co stock appears to be overvalued. The current stock price of 円2,525.00 is trading 1.9% above its estimated GF Value™ of 円2,477.93. GuruFocus considers Eiken Chemical Co to be Fairly Valued.

Key valuation signals for TSE:4549:

  • ROCE %: 1.01%
  • GF Value™: 円2,477.93 vs. price of 円2,525.00 (1.9% above fair value)
  • GF Score™: 81/100 with 4 warning signs
  • Industry Position: 54.7% below the Medical Devices & Instruments median

No single metric tells the full story. See the TSE:4549 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eiken Chemical Co Business Description

Address 4-19-9 Taito, Taito-ku, Tokyo, JPN, 110-8408
Eiken Chemical Co Ltd is a Japan-based company. It manufactures and sells clinical diagnostics and equipment. The company is engaged in processing, manufacture, purchase and sale of test agents, property and casualty insurance agency business. It as a general manufacturer of clinical diagnostics offers a wide range of in vitro diagnostic aids for all fields of medicine. Its major products include the Fecal immunochemical test, Molecular Genetics (LAMP), Microbiology, among many others.
81GF Score

Get the complete analysis for TSE:4549

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,525.00
Price
円2,477.93
GF Value